Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Cash | 1.30 | 1.55 | 0.25 |
| Shares | 98.71 | 98.71 | 0.00 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 17.27 | 19.20 |
| Price to Book | 3.32 | 3.78 |
| Price to Sales | 1.64 | 2.18 |
| Price to Cash Flow | 12.79 | 14.31 |
| Dividend Yield | 1.40 | 1.48 |
| 5 Years Earnings Growth | 8.68 | 9.85 |
| Name | Net % | Category Average |
|---|---|---|
| Healthcare | 98.93 | 94.97 |
| Industrials | 1.07 | 2.57 |
Number of long holdings: 55
Number of short holdings: 4
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| AstraZeneca | GB0009895292 | 5.87 | 14,100.0 | +1.19% | |
| Eli Lilly | US5324571083 | 5.69 | 1,102.41 | +3.01% | |
| UnitedHealth | US91324P1021 | 4.77 | 327.65 | +2.69% | |
| Novo Nordisk B | DK0062498333 | 4.50 | 300.0 | +4.53% | |
| Boston Scientific | US1011371077 | 3.81 | 101.06 | +3.08% | |
| Thermo Fisher Scientific | US8835561023 | 3.79 | 600.25 | +2.42% | |
| AbbVie | US00287Y1091 | 3.49 | 233.42 | +1.70% | |
| Sanofi | FR0000120578 | 3.33 | 86.39 | +0.51% | |
| Fresenius SE | DE0005785604 | 3.18 | 47.660 | +0.97% | |
| CVS Health Corp | US1266501006 | 2.91 | 78.77 | +1.11% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| AXA Framlington Global Technology F | 1.12B | 23.05 | 22.19 | 20.28 | ||
| AXA Framlington Global Technology a | 1.12B | 23.11 | 22.21 | 20.29 | ||
| GB00B5LXGG05 | 1.01B | 6.30 | 16.32 | 16.39 | ||
| AXA Framlington Managed Income Funr | 285.95M | 6.85 | 8.56 | 4.33 | ||
| AXA Framlington Managed Income Fund | 285.95M | 7.30 | 9.09 | 4.85 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review